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AIM 
To identify the histopathological features useful in distinguishing tuberculosis from 
Crohn’s disease in mucosal biopsies from the upper gastrointestinal tract with 
granulomatous inflammation. 
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OBJECTIVES 
 
A] To conduct a detailed histopathological study of mucosal biopsies from the 
upper gastrointestinal tract with granulomatous inflammation. 
 
B] To identify the pathological features that may be useful in differentiating 
tuberculosis from Crohn’s disease using the above data. 
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LITERATURE REVIEW 
INTRODUCTION 
 
Since the first ever description of Crohn's disease in the terminal ileum, it has 
been identified in all parts of the gastrointestinal tract i.e. from the mouth to 
the anus(1) . Until few years ago, involvement of the upper gastrointestinal 
tract was thought to occur only in 1-5% of Crohn's disease patients. However, 
because of the more frequent use of upper gastrointestinal endoscopy, recent 
reports show substantially higher incidence rates. Cameron et al demonstrated 
an incidence of 71% in a prospective study involving the paediatric 
population(2) and in a retrospective study, Laenart et al reported an incidence 
of 30%(3). A high incidence of upper gastrointestinal involvement in an adult 
population, of up to 60%, was described by Schmitz-Moormann et al(4). 
Crohn's disease of the upper gastrointestinal tract generally occurs in 
conjunction with involvement of the lower gastrointestinal tract. General use 
of colonoscopy in recent years has led to awareness of endoscopic and 
histological alterations of the lower gastrointestinal tract in Crohn's disease. In 
contrast, systematic detailed studies of histological changes in the upper 
gastrointestinal tract have scarcely been reported (4). 
 
Tuberculosis involving the upper gastrointestinal tract is a rare disease and 
the gastrointestinal tract is only the sixth most common site of extra 
pulmonary tuberculosis. However in developing countries like India, the 
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menace of tuberculosis has never been controlled whereas in industrialized 
countries, the incidence of tuberculosis has started to rise again owing to the 
increased incidence of HIV/AIDS. This highlights the importance of a 
comprehensive assessment of the histological changes noted in Tuberculosis 
of the upper gastrointestinal tract (5). 
 
Tuberculosis and Crohn’s disease are both granulomatous diseases of the 
gastrointestinal tract with numerous overlapping features. Distinguishing 
between the two entities is of paramount importance, as an incorrect 
diagnosis and thereby inappropriate management is associated with increased 
mortality and morbidity. 
 
CLINICAL FEATURES 
 
Crohn's disease 
 
Esophagus: The esophagus is considered to be one amongst the least common 
segments of the gastrointestinal tract involved in Crohn's disease and isolated 
involvement is rare(1,6,7).  The first ever case of esophageal CD was 
described by Frank and Taylor in 1950 (8). However, even 65 years later its 
true prevalence is still elusive. The prevalence of esophageal Crohn's disease 
has been described to range from 1-2% in adults to upto 40% in children and 
adolescents (9–12). 
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The average age at presentation is reported to be around 40 years (6), though 
studies show an increasing incidence in children and adolescents (11). There 
is no documented sex difference (6). 
 
Patients with esophageal CD in the early stages may be asymptomatic. 
Odynophagia, dysphagia and sometimes severe weight loss are the 
presenting symptoms in patients with advanced esophageal CD and amongst 
these dysphagia is the most common presenting complaint(1,6,13). Rarely, 
fistulisation and bleeding may occur and when present, they generally 
indicate a more threatening aspect of the disease (10). 
 
Gastro-duodenum: The entity of gastric CD was first described by Ross et al in 
1949(14). Thereafter, the prevalence of gastroduodenal disease has been reported to 
range from 5-60% in adults(9). Gastroduodenal CD has also been reported to be more 
common in the paediatric population than adults(15). The antrum is most commonly 
involved and duodenal CD is usually associated with antral involvement (6). 
 
Patients with gastroduodenal CD are generally asymptomatic. Epigastric abdominal 
pain is the most common symptom in gastroduodenal CD. Loss of weight, general 
malaise, vomiting and diarrhoea are other common symptoms(16,17). Wagtman et al 
reported that the only symptoms that statistically differ between patients with upper 
gastrointestinal CD and patients with distal CD are abdominal pain and malaise(18). 
 In more advanced diseases, particularly when obstruction has developed, epigastric 
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distress, early satiety, nausea, vomiting and weight loss are the predominant 
symptoms (1,9,19). 
 
Complications such as hematemesis or melena due to acute or chronic blood loss 
from the upper GIT are rare (1). 
 
Tuberculosis 
 
Esophagus: Most cases of esophageal tuberculosis which have been reported are 
secondary to tuberculosis elsewhere, commonly pulmonary tuberculosis. The 
prevalence of esophageal tuberculosis in a large autopsy series was only 0.15% (5). 
Primary esophageal tuberculosis, without evidence of tuberculosis elsewhere, is 
considered to be a rarity worldwide (20), however, it may not be so uncommon in 
developing countries like India. 
 
The esophagus is considered to be intrinsically protected from TB by the following 
features – the stratified squamous epithelial lining, mucosal coating by saliva and 
mucous, tubular structure and rapid peristaltic transit of swallowed material that 
prevents stasis and mucosal invasion(21). 
 
The middle one third of the esophagus at the level of the carina is the most 
commonly involved site in esophageal tuberculosis. This is usually caused by 
spread of infection from tuberculous mediastinal lymph nodes by way of a draining 
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fistula (5,22). On rare occasions the proximal third of the esophagus can be 
involved by direct extension from tubercular laryngitis or pharyngitis(5). 
 
The most common presenting symptom in esophageal tuberculosis is dysphagia 
which occurs in 90% of the cases (5,20,22). Dysphagia can be due to intrinsic 
tuberculous involvement of the esophagus or due to esophageal compression by 
mediastinal tuberculous lymph nodes (5,20). Other symptoms include odynophagia, 
retrosternal pain, fever and weight loss (5,22,23). 
 
Complications include esophageal strictures, stenosis, fistulae and bleeding. The 
strictures may result from esophageal compression by mediastinal lymph nodes. 
Esophagotracheal and esophagomediastinal fistula are frequently described in 
esophageal tuberculosis (21). 
 
Massive bleeding has been reported to occur due to deep penetration of the 
tuberculous ulcer into the aorta with resultant esophago-aortic fistula (24). 
 
Stomach: Gastric tuberculosis most commonly occurs secondary to a pre-existing 
pulmonary infection and cases of isolated and primary gastric TB without evidence 
of lesions elsewhere have rarely been reported (25). The reported incidence of 
primary gastric TB is <0.02% on routine gastric biopsies. However, the incidence 
increases dramatically to 4.5% in individuals with moderate pulmonary TB and up to 
25% in those with severe disease (25). 
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Primary and isolated gastric tuberculosis is considered to be rare due to the surface 
integrity of the gastric mucosa, local immunity of the stomach wall, rapid emptying 
of stomach contents, bactericidal properties of gastric acid and paucity of lymphoid 
tissue in the gastric wall (26–28). Possible routes of infection include direct invasion 
through the mucosa, haematogenous spread, lymphatic spread or contiguous spread 
through the serosa (29). 
 
Gastric tuberculosis is seen more frequently in males as compared to females (29). 
Also, it is three to four times more common in adults than in children (29).The age of 
onset is 20-40 years of age. 
 
Tuberculosis most commonly occurs in the antrum and lesser curvature of the 
stomach. 
 
The clinical manifestations of gastric TB are varied and nonspecific. Subjective 
complaints like intermittent epigastric discomfort, weight loss, hematemesis and 
features of gastric outlet obstruction may be present (30,31). However, gastric outlet 
obstruction as the primary manifestation is rare (32). Systemic manifestations such as 
low grade fever, malaise and weight loss can also be present. 
 
As gastric tuberculous ulcers rarely penetrate the muscle layer, perforation is rare (31). 
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Duodenum: The prevalence of duodenal TB ranges from 2%-16.5% based on different 
studies (33,34). Duodenal tuberculosis generally occurs secondary to pulmonary 
involvement (32) and duodenum is considered to be the fourth most common site of 
GI tuberculosis involvement (23). The most common site of involvement is the 
proximal duodenum. 
 
Duodenal tuberculous involvement can be either extrinsic or intrinsic(33,35). The 
extrinsic type is more common than the intrinsic type and is considered to occur due 
to periduodenal lymph node compression (33). Intrinsic lesions could be ulcerative, 
hypertrophic or ulcero-hypertrophic (33,35). 
 
The clinical presentation of duodenal TB is classically divided into obstructive and 
dyspeptic (33). Gupta et al noted that 73% of patients presented with features of 
gastric outlet obstruction and 27% had dyspeptic symptoms (36). Chavhan et al also 
has described a predominance of obstructive symptoms (37). Patients with extrinsic 
involvement and the hypertrophic type of intrinsic involvement generally present with 
obstructive symptoms and those with the ulcerative type of lesion present with 
dyspeptic symptoms (33). Most of the times the obstruction is the result of both, 
extrinsic compression by the enlarged lymph nodes and the narrowing caused by 
intrinsic involvement acting together (37). 
 
The most common presenting complaints in duodenal TB are epigastric pain and 
vomiting (38). Complications like fistulae, perforation and haemorrhage have been 
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reported in various case reports (33). A case report of acute perforation of 
tuberculous duodenal segment has been reported by Berney et al (39). Infrequently, a 
fistulous communication can occur between the duodenum and renal pelvis or bile 
duct (38). 
 
 
RADIOLOGY 
 
Crohn’s disease 
 
Esophagus:  Radiological findings are generally less informative in Crohn’s disease, 
however, thickened mucosal folds or cobblestones and irregular asymmetric mucosal 
defects such as aphthous or deep ulcers are the few of the common radiological 
features of esophageal CD(1,12). A fibrotic stenosis may develop in advanced cases 
(1,9). Spontaneous fistulae can also develop because of the transmural nature of CD 
(1). 
 
Gastro-duodenum: Aphthous ulcers are the earliest detectable radiologic signs and 
are demonstrated by the double contrast technique. Other common radiologic signs 
include thickened folds, cobble stoning and ulcerations (1,19,40). Stricture formation 
can give rise to some specific radiologic features: tubular narrowing, a 'ram horn's 
sign' or a pseudo Billroth I configuration (when the stomach and duodenum are both 
involved) (19,41). 
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Tuberculosis 
 
Esophagus: CT of the thorax is recommended in cases of suspected esophageal TB, 
not only to detect the secondary nature of the disease (via mediastinal lymph nodes) 
but also to detect extra luminal complications  like perforation and 
pneumomediastinum (21). 
 
Stomach: The radiological appearances in gastric tuberculosis are predominantly 
ulcerative and hyperplastic (31). Thickening of the gastric wall, with associated 
enlarged lymph nodes, often visible via CT, may sometimes be the only clue to the 
diagnosis (38). 
 
Duodenum: Duodenal TB lacks specific radiological features however, barium studies 
help in the localization and recognition of the site and extent of narrowing and 
ulcerations (33,37). The radiological findings noted in duodenal TB with an 
obstructive presentation are luminal narrowing of varying degrees and a sharp, band 
like cut off of the duodenum at the D2-D3 junction. In patients with the dyspeptic 
presentation, the radiological findings include luminal narrowing at the second and 
third part of the duodenum, ulcerations in the second to fourth parts and extrinsic 
compressions at the third to fourth parts of duodenum (37). Other findings include 
scarred and deformed duodenal cap and widening of the C loop of the duodenum 
(33,37). Occasionally, duodenal TB may present as polypoidal intraluminal soft tissue 
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mass (33). CT may show thickening of the duodenal wall with lymph node 
enlargement (42). 
 
ENDOSCOPY 
 
Crohn's disease 
 
Esophagus: The morphologic changes in Crohn's disease is mainly noted in the lower 
third of the esophagus (1,6). There are no pathognomic endoscopic features for 
esophageal Crohn’s disease(12).  One of the common endoscopic changes, however, 
are the nonspecific aphthoid ulcerations which are small discrete ulcers surrounded by 
a red halo of edematous tissue(6,12,43). Multiple aphthoid ulcerations with 
intervening normal mucosa gives rise to a 'cobblestone appearance'(6,12). Other 
endoscopic findings include mucosal erythema, slight friability of mucosa, 
granularity, nodular thickening and mucosal defects such as erosions and deep 
ulcerations (1,6,44,45). Marked fibrosis leading to stenosing lesions has been reported 
to be one of the complications of esophageal CD(6). Huchzermeyer described two 
stages in esophageal CD: Stage I, wherein inflammatory changes in the form of a mild 
or more frequently erosive-ulcerative esophagitis are noted, and Stage II, wherein a 
stenosing form is observed (46). 
 
Stomach: Abdullah et al reported the incidence of endoscopic abnormalities in 
gastric CD to be about 64%(47).The mucosal lesions are most commonly seen in the 
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antro-pyloric region (1,4,6,19,48).The most frequent gastric mucosal lesions in CD 
are mucosal redness, mucosal edema(frequently with curtain folds), linear and 
serpiginous ulcerations and aphthous ulcers along with acute and chronic 
erosions(4,48). Other lesions usually noted are nodularity, granularity, cobble 
stoning and thickened mucosal folds (1,4,6,19,48,49). Amongst these, superficial 
ulcerations and aphthous ulcers have been described as probably the earliest 
recognisable manifestations of gastric CD.  In gastric CD, the ulcers and erosions are 
generally longitudinal or serpiginous. A feature that helps to differentiate them from 
peptic ulcers(50). 
 
Schmitz-Moormann et al and Gad et al demonstrated that chronic erosions have a 
significant correlation with the presence of granulomas. This indicates that only 
chronic erosions constitute a characteristic endoscopic lesion for gastric CD, whereas 
other generally cited lesions do not reveal such specificity (4,51). Occasionally, a 
linitis plastica appearance with luminal narrowing and rigidity may be noted and is 
suggestive of diffuse gastric involvement (19).  Obstruction in the pyloric region due 
to scarring is also seen to occur in majority of gastroduodenal Crohn’s disease(18). 
 
It must be remembered that normal endoscopic findings, however, does not rule out 
the histological presence of focal gastritis(48). Oberhuber et al, noted that 25% of 
patients with Crohn's disease who had normal endoscopic findings showed 
histological evidence of focal gastritis (26). 
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Duodenum: Mucosal redness, mucosal edema and aphthous lesions are the most 
frequent endoscopic lesions noted in duodenal CD. Other lesions noted are 
granularity, nodular mucosal lesions, ulcers, stenosis and insufficient distensibility. 
However, only three lesions namely mucosal redness, ulcers and stenosis correlate 
significantly with the presence of granulomas. These lesions resemble the 
endoscopic features of CD in the lower gastrointestinal tract (4).  
 
Tuberculosis 
 
Esophagus: Three distinct morphological mucosal lesions are noted in 
esophageal tuberculosis - ulcerative, hypertrophic or granular. 
 
Ulcerative lesion - The most common macroscopic finding is a midesophageal linear 
ulceration with smooth edges and a membranous necrotic base. The ulcers are 
generally multiple, fairly large in size (24). The surrounding mucosa appears normal 
with or without evidence of stricture. A similar endoscopic picture is not usually seen 
with any other condition and therefore in patients with appropriate histories and 
distinctive midesophageal ulcerative lesions, the diagnosis of esophageal tuberculosis 
should be considered (5,20,24). 
 
The mycobacteria bacilli initially involve the esophageal submucosa 
followed by the formation of tubercles. With disease progression, caseous 
necrosis occurs within the nodules, eventually leading to ulceration (52). 
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Generally, the tuberculous ulcers are superficial. The more serious ulcers which 
rarely occur, often can penetrate the muscularis layer and breakthrough the adventitia 
resulting in perforation and fistulae. Such deep ulcers also have been described to 
bleed easily (52). 
 
Hyperplastic lesion – This lesion occurs due to excessive amount of tuberculous 
inflammatory granulation tissue and fibrous hyperplasia. Occasionally massive 
hyperplasia can result in a false tumour like mass (pseudo tumour) formation in the 
esophageal lumen and cause luminal narrowing. 
 
Granular lesion – This is the least common lesion and is seen in severe systemic 
disease wherein the mucosa and submucosa show many gray-white nodules 
(52). 
 
Stomach: In gastric TB, the gross lesions may be of 4 types, as described by 
Broders– ulcerative, hypertrophic, tumour type or inflammatory 
type(25,27,53,54). 
 
Ulcerative lesion - The most common lesion is the ulcerative lesion (80%) which is 
usually seen along the lesser curvature (27,53,54). Typically the ulcer has a 
serpiginous outline. The ulcer also has characteristic undermined edges which are not 
seen in any other gastric disease. The undermined edges are typically ragged, 
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edematous and grossly inflamed. Discrete tubercles are generally present at the edge 
of the ulcer. The granulomatous base is characteristically dirty gray brown and may 
be covered with discernible tubercles(54). 
 
The ulcer is believed to develop as a result of fistula formation from a submucosal 
focus. Small submucosal tubercles undergo caseation and suppuration and produce 
multiple fistulae through the mucosa into the gastric lumen. Ulcers further develop 
by the numerous irregular ruptures of the mucosa, giving rise to the serpiginous 
outline of the ulcer (54). 
 
Hypertrophic lesion - The hypertrophic lesion is seen more frequently in the antrum 
and is characterized by submucosal infiltration. The infiltration may spread through 
the wall resulting in a linitis plastica like appearance. Cicatrisation with gastric 
obstruction is a common sequelae. The mucosal surface generally remains intact in 
an early lesion. However, as a consequence of the mass of the lesion and 
mechanical interference with the action of the muscularis mucosae, the gastric 
rugae get obliterated. 
 
Tumour type lesion - The main characteristic of this lesion is the discrete nature of 
the mass. This lesion tends to caseate early and is associated with liquefaction, 
fistulisation and ulceration. 
 
Superficial tubercles are common in the neighbourhood of all tuberculous lesions(54). 
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Duodenum: .The macroscopic lesions noted in duodenal TB are described to be 
ulcerative, hyperplastic or ulcerohypertrophic(31,39,42) . Ulcerative lesions are the 
most common findings and accounts for 60%. The ulcers are generally 
circumferential and surrounded by inflamed mucosa. Ulcerohypertrophic accounts 
for 30% and show and inflammatory mass with a thickened and ulcerated mucosa. 
The hypertrophic lesion is the least common lesion (10%) and is characterized by 
scar, fibrosis and pseudo tumour formation (42). 
 
 
HISTOPATHOLOGY 
 
Crohn's disease 
 
In the diagnosis of CD in the upper gastrointestinal tract, histopathological findings 
are of much greater predictive significance than endoscopic findings (4). Many 
investigators have used the criteria proposed by Nugent and Roy for the definition of 
Crohn's disease of the upper GI tract:- 
 
i. Non caseating granulomatous inflammation on endoscopic biopsies in the 
upper gastrointestinal tract, with or without Crohn's disease elsewhere in 
the intestinal tract, and without evidence of a systemic granulomatous 
disorder.  
18 
 
 
ii. Crohn's disease of the small or large intestine and radiological and/or 
endoscopic findings of diffuse inflammatory change in the upper 
gastrointestinal tract consistent with Crohn's disease (1).  
 
Esophagus: Isolated involvement of the esophagus is rare in Crohn's disease. 
Esophageal CD is generally associated with advanced ileo-colonic disease (11). At 
the outset, it is important to note that the transmural nature of CD cannot be 
accurately assessed on superficial mucosal biopsies and moreover there are no 
pathognomic histological features for esophageal CD (12,55).  
Nevertheless, esophageal mucosal biopsies on histological evaluation usually 
demonstrate focal inflammation and infrequently granulomas (4).  
A lymphocytic infiltrate within the lamina propria is one of the most consistent 
findings in esophageal CD(12). Focal infiltration with mononuclear cells and 
histiocytes into the lamina propria extending up to the muscular layer is considered 
to be histologic evidence of esophageal CD(11). 
 
Non caseating epithelioid granulomas, are generally uncommon, but when seen, are 
considered to be diagnostic for esophageal CD (1,6,11,12,56). Esophageal 
granulomas are situated generally in the submucosa, at a depth, which is only barely 
reached by regular esophageal mucosal biopsies. It has been postulated that with 
additional sectioning, the detection rate of granulomas can be increased (4).  
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Additionally, Rubio et al observed that 40% of cases with lymphocytic esophagitis 
were diagnosed to have Crohn's disease (57)whereas Purdy et al observed only 12% 
to have CD (58). The main criteria for diagnosing lymphocytic esophagitis is the 
occurrence of high number of intraepithelial lymphocytes (IEL) and not more than 
rare granulocytes (57,58). Both the peripapillary and inter papillary areas must be 
examined to assess the severity of IELs. Peripapillary is defined as the first five 
layers of squamous epithelium surrounding the esophageal papillae. The lymphocytic 
esophagitis was graded mild if it predominantly involved the peripapillary area and 
severe if it involved both the interpapillary and peripapillary areas (58). 
 
Another important feature is the presence of intraepithelial lymphocytes with 
irregular nuclear contours (11,56). The peripapillary areas are usually rich in round 
IELs and the interpapillary regions are rich in IELs with irregular nuclear contours 
(57). It has been postulated that these irregular lymphocytes mirror cell 
deformation brought about by emperipolesis, which is one of the mechanisms of 
lymphocyte transmigration within the squamous epithelium. This may reflect a 
mechanism that is necessary to circumvent to the barrier of strong desmosomes 
present in the intercellular spaces of the squamous epithelium. Rubio et al observed 
that the transmigration seems to take place from the peripapillary fields to the 
interpapillary fields (57). 
 
Stomach: To date, demonstration of non caseating epithelioid granulomas has been 
considered to be the histological hallmark for the definitive diagnosis of 
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gastroduodenal Crohn's disease(26,48). However, in addition to the granulomas, 
focally enhanced gastritis has found to be a significant pattern of inflammation that is 
frequently found in gastric mucosal biopsies of patients with Crohn's disease 
(4,26,48). And these focal lesions are comparable to similar lesions that have long 
been described as an important histological feature in lower GI Crohn's disease (48). 
The presence of mucosal edema, foveolar abscesses, erosions, ulcerations, fibrosis 
and lymphoid aggregates have also been noted consistently in Crohn's disease. 
However, none of these mucosal findings by itself indicates a diagnosis of Crohn's 
disease (1,51). It has been postulated that the analysis of the localization and 
morphological features of the granulomas together with associated surrounding 
changes yields much more information than mere granulomas alone (26). 
 
GRANULOMAS – The prevalence of granulomas in gastroduodenal Crohn's 
disease varies tremendously from study to study ranging from 6.5%-
68%(48,51,59,60). Schmitz Moormann reported the prevalence of non caseating 
epithelioid granulomas to be only 22.4% in gastric CD and Oberhuber reported a 
prevalence of 16%(4,26).The differences in the prevalence of granulomas amongst 
different studies have been attributed to the different methodological factors as well 
as the nature and extent of the disease (48,51). Granulomas are seen more 
commonly in the stomach as compared to the duodenum. Gastric granulomas are 
significantly more common in young patients and more frequently involve the 
antrum (48,51). 
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Biopsies from endoscopically visualized erosions generally yield a high rate of 
granulomas. However, granulomas have also been described in endoscopically normal 
mucosa. In a series reported by Gad et al, granulomas were detected in 16% of cases 
with endoscopically normal mucosa(4,51) 
 
The granulomas are characteristically small in size and are preferentially described as 
micro granulomas (51). They are usually superficially located in the lamina propria 
and are associated with few or no giant cells(51). 
 
Location of the granulomas in the foveolar isthmi/glandular areas, and direct contact 
between the granuloma and a damaged epithelial structure are more suggestive of 
Crohn's disease. Furthermore, if the granulomas are small/loosely arranged or 
associated with focally enhanced gastritis, a diagnosis of Crohn's disease is more 
likely(26). 
 
In gastroduodenal mucosal biopsies from previously diagnosed lower GI Crohn's 
disease, the presence of granulomas, especially micro-granulomas, is conclusive of 
proximal GI involvement. However, in primary Crohn's disease of the gastroduodenal 
region other causes of granulomatous inflammation such as TB, sarcoidosis, foreign 
body reaction and primary granulomatous gastritis have to be considered in the 
differential diagnosis(51). 
 
FOCALLY ENHANCED GASTRITIS – In previously diagnosed cases of lower 
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GI Crohn's disease, Oberhuber et al observed focally enhanced gastritis in 71.4% 
of H.pylori negative gastric mucosal biopsies,  Meining et al described it in 
63.9% of gastric biopsies,  Schmitz-Moorman et al in 38% cases and Parente et 
al in 40% cases (4,26,61,62) 
 
Endoscopically hyperemia and mucosal lesions may indicate focally enhanced 
gastritis, however, it must be stressed that focally enhanced gastritis may also 
be found in endoscopically normal mucosa (4,26). 
 
Focally enhanced gastritis is described as a lesion wherein one foveolus or small 
clusters of foveolae/ gastric glands are surrounded by a sharply demarcated 
inflammatory infiltrate and occasionally infiltrated by inflammatory cells 
predominantly composed of lymphocytes, histiocytes and few granulocytes. These 
lesions are usually detectable at low power magnification(26,61,62).  They are located 
either at the level of the foveolar isthmus or deep within the glandular layer (26). It 
has been observed that such lesions, if present in the antrum and angulus (incisura), 
appear to be highly associated with Crohn's disease (26,61). 
 
On immunohistochemical examination, Oberhuber et al noted that the hallmark of 
focally enhanced gastritis was a periglandular or perifoveolar collection of CD3+ 
lymphocytes and CD68R+ histiocytes, which was consistent with CD associated 
lesions in the lower GI. These lesions are generally devoid of CD20+ lymphocytes. 
This feature was not observed in any other type of gastritis (26,62). 
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Parente et al have also described that focally enhanced gastritis shows a good 
specificity (84%) and a positive predictive value of 71% in cases of gastric CD, 
however it is not a sensitive feature of gastric CD (62). 
Helicobacter pylori: The prevalence of H.pylori is generally observed to be low in 
patients with Crohn's disease(60,61). However, it is important to document the 
presence of Helicobacter pylori in gastric mucosal biopsies, as H.pylori associated 
gastritis may veil focally enhanced gastritis because H.pylori colonization can itself 
induce a focal accumulation of neutrophilic granulocytes. Focally enhanced gastritis 
can, therefore, only be appreciated in H.pylori negative cases (26,60). 
 
The positive predictive value of focally enhanced gastritis is 97.5%. Therefore, the 
index of suspicion of Crohn's disease should be high in patients with H.pylori 
negative focally enhanced gastritis (26,61). However, since these inflammatory 
reactions are only focally distributed in the gastric mucosa and can be even 
associated with endoscopically normal mucosa, bias due to sampling error during 
endoscopy may occur. It has, therefore, been suggested that if upper GI endoscopy 
is performed to diagnose Crohn's disease, biopsy samples should be taken from the 
antrum (preferably lower curvature), corpus (preferably lower third of the anterior 
wall) and the angulus (6,61).  
 
Duodenum: Inclusion of a duodenal biopsy is considered to be an essential 
component of the diagnostic workup for upper GI Crohn's disease, as isolated 
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duodenal involvement is more frequent than isolated Crohn's disease of the stomach 
(1,48). Duodenal biopsy specimens are obtained from both the bulbar and postbulbar 
mucosa. An important advantage of including duodenal tissue, particularly the post 
bulbar duodenal mucosa, is that it is rarely affected by H.pylori infection thereby 
eliminating any confounding factors (48). 
 
The second part of the duodenum is most commonly affected, although any part can 
be involved (1). The histopathological features of duodenal Crohn's disease are 
considered to be similar to those in the stomach. The presence of granulomas were 
noted in only 5% of duodenal CD cases in a series conducted by Hardee et al(15). 
 
 With the exclusion of granulomas, focal cryptitis seems to be the most distinctive 
feature in duodenal biopsies of patients with Crohn's disease (15,63). Tobin et al 
noted the incidence of duodenal cryptitis to be 26%(64) and suggested that cryptitis 
could be a significant finding in duodenal CD. Focal cryptitis shows a specificity of 
99% and positive predictive value of 93% (63).  
 
Hardee et al also noted that villous atrophy and crypt hyperplasia of varying degrees 
were frequently observed in duodenal CD(15) . 
 
The prevalence of increase in intraepithelial lymphocytes in duodenal mucosal 
biopsies of patients with CD was noted to be 15% in a study by Tobin et al (64). 
Patterson et al postulated that Crohn's disease should be included in the differential 
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diagnosis of increase in intraepithelial lymphocytes with normal villous architecture 
in duodenal mucosal biopsies as they noted that 5% of patients with increase in 
intraepithelial lymphocytes were subsequently diagnosed with Crohn's disease(65). 
They also suggested that a combination of increased duodenal IELs and focal gastritis 
increase the chances of CD as a diagnosis(65). 
 
Additionally, lymphangectasia, crypt abscess and focal gastric metaplasia of the 
duodenal mucosa have also been noted (51). 
 
 
Tuberculosis 
 
Histopathologic criteria for diagnosis of gastric tuberculosis described by Broders: 
 
1. A positive diagnosis can be made, if tubercle bacilli can be demonstrated in the 
depths of the histologically tuberculous lesion.  
2. Diagnosis is probable, if there is a good histological picture of tuberculosis 
without bacilli  
3. Diagnosis is possible, if there is a good description of the gross lesions of 
tuberculosis.  
 
Patients are histologically diagnosed to have Tuberculosis if they show evidence of 
epithelioid granulomas with or without caseation and/or the presence of acid fast 
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bacilli on histopathological examination (4,22,39).  Zeil Neelsen staining has to be 
performed for identification of acid fast bacilli (5).  
 
With respect to gastric TB, granulomas are usually present in the submucosal and sub 
serosal layers and usually a nonspecific inflammatory lesion is seen in the mucosa. 
These biopsy findings are probable reasons for failure of endoscopic diagnosis (27). 
 
Microscopy, although cheap and sensitive, has a low sensitivity (40-60%) and can 
identify acid fast bacilli in only around 25% of patients with extra pulmonary 
disease (24,66). It has been noted that identification of acid fast bacilli from 
endoscopic biopsy samples is difficult due to the paucibacillary nature of GI 
tuberculosis(32,38). 
TUBERCULOSIS AND CROHN’S DISEASE IN THE LOWER 
GASTROINTESTINAL TRACT. 
Endoscopy 
Lower GI endoscopy can provide crucial information to help in differentiating 
between lower GI tuberculosis and Crohn’s disease. The frequency of endoscopic 
involvement of the different sites in the lower GIT is similar in tuberculosis and 
Crohn’s disease except for the rectum that is generally not involved in intestinal 
tuberculosis(67).  Many features namely odematous mucosa, mucosal ulcerations, 
nodularity, luminal narrowing, strictures and pseudopolyps can occur in both 
conditions(68).  
One of the most distinguishing feature is that ulcers in CD occur on a normal 
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appearing mucosa, whereas in TB colitis the mucosa surrounding the ulcer has 
reactive changes such as erythema, nodularity or edema(68,69). Also, a cobblestone 
appearance of mucosa is strongly suggestive of Crohn’s disease, although it has also 
been reported in TB as well. Skip lesions, aphthous ulcers and longitudinal deep, 
fissuring ulcers are significantly more frequent in CD. Transverse ulcers are 
classically observed in intestinal TB(70,71). 
Pathology 
Crohn’s disease: Terminal ileum with proximal right colon is the most common site 
involved in CD(72). Diseased areas are admixed with uninvolved areas of normal 
bowel leading to the rise of ‘skip-lesions’. The earliest grossly visible lesions are 
small aphthous ulcers that typically develop over lymphoid follicles. As the aphthous 
ulcers enlarge, they coalesce to form larger serpiginous ulcers with heaped up 
edematous margins(73). In CD, the pathology extends transmurally and hence, serosa 
may show adhesions or serosal exudates. As the disease becomes chronic, stricture 
formation occurs at sites of transmural inflammation 
Histologically, CD is associated with chronic inflammation and architectural changes 
in the mucosa, though the changes tend to be patchy or focal. Architectural alteration, 
cryptitis, crypt abscesses, crypt distortion and basal plasmacytosis are common 
features of CD. Another characteristic feature is the presence of characteristic non 
caseating, small granulomas composed of epithelioid histiocytes. Pericryptal 
granulomas found in isolation are more likely found in CD(71,74,75). 
Intestinal tuberculosis: ITC causes ulceration, short strictures and marked thickening 
of the bowel wall due to inflammation, fibrosis and adhesions. The ulcers are 
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transverse, often circumferential, with ill-defined, sloping or overhanging edges.  
The histological hallmarks of ITB are confluent, caseating granulomas containing acid 
fast bacilli and surrounded by a lymphoid cuff.  These are found in all layers of the 
intestinal wall and in the regional lymph nodes(68). Other common microscopic 
features are aphthous ulcers over lymphoid follicles, fissuring ulcers that extend into 
muscularis propria or deeper, mucosal architectural distortion, pyloric gland 
metaplasia, cryptitis and crypt abscess formation with moderate to severe chronic 
inflammation(68). 
 
OTHER INVESTIGATIONS 
Elevated ESR and C reactive protein are common findings in the active phases of both 
tuberculosis and Crohn’s disease(70,76). 
AFB smear and culture: Culture is the only definitive diagnostic test to isolate 
Mycobacterium tuberculosis bacilli. Another unerring test is the demonstration of acid 
fast bacilli by smear examination. However, it must be noted that tubercle bacilli are 
seldom isolated from esophageal lesions and gastric secretions(5).  
PCR Assay: Polymerase chain reaction amplification reaction of Mycobacterial DNA 
has been noted to improve the rate of detection (38). TB PCR is highly specific for GI 
tuberculosis, but has poor sensitivity (77). 
QuantiFERON TB GOLD: A recent study reported high sensitivity (86%), specificity 
(100%), positive predictive value (100%) and negative predictive value (88%) for the 
QuantiFERON TB GOLD test in detecting extra pulmonary tuberculosis(78). 
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Conclusion 
Crohn’s disease and tuberculosis are chronic granulomatous diseases with many 
overlapping features. The shifting global map of the two disease with increasing 
numbers of cases of TB being recognised in the developed countries in the backdrop 
of the HIV epidemic and the materialisation of CD in developing nations where it was 
previously not recognised, has made distinguishing these two diseases crucial with 
respect to patient management. To the best of our knowledge, no studies have 
attempted to distinguish tuberculosis from Crohn’s disease in the upper 
gastrointestinal tract. Our study is unique, in that we aim to conduct a detailed 
histopathological study of mucosal biopsies with granulomatous inflammation of 
patients with upper gastrointestinal TB and CD, and identify the pathological features 
that may be useful in differentiating these two conditions.  
 
 
 
 
  
 
 
 
 
 
 
 
 
 
 
 
 
MATERIALS AND METHODS 
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MATERIALS AND METHODS 
 
The study was performed in the Department of General Pathology during the time 
period December 2015-August 2016 using the archival stained and mounted 
Haematoxylin and Eosin (H&E) slides and formalin fixed paraffin embedded blocks. 
Prior to initiation, our study was approved by the Institutional Review Board and 
Ethics committee of Christian Medical College. 
Forty cases were selected from a total of 98 mucosal biopsies with granulomatous 
inflammation from the upper gastrointestinal tract (esophagus, stomach and 
duodenum) over a ten year period (January 2005-December 2014). 
Inclusion criteria: Only cases with a final clinical diagnosis of Crohn’s disease or 
Tuberculosis based on a combination of clinical history, laboratory parameters, 
radiological findings, endoscopic findings, response to treatment and with a minimum 
of 1 year of follow up information were selected.  
Exclusion criteria: 
 Cases in which final diagnosis is ambiguous  
 Cases that do not have 1 year follow up.  
 Referral cases – slides and blocks for review 
The clinical, endoscopic, radiological and histopathological data of these cases were 
reviewed by a gastroenterologist. A database was created in the Epidata software for 
the entry of clinical, endoscopic and histopathological data of each case. 
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CLINICAL DATA 
Clinical data and laboratory data of the patients, including ESR (Erythrocyte 
sedimentation rate), CRP (C-reactive protein), AFB smear, Xpert TB PCR, 
QuantiFERON Gold, TB culture, endoscopic findings and radiological investigations 
were obtained from the Computerised Hospital Information System and patient charts 
with the help of a gastroenterologist.  
The clinical symptoms recorded included the presence or absence of dyspepsia, 
vomiting, diarrhoea, melena, fever, loss of weight, loss of appetite, abdominal pain, 
fistula in ano and extra-intestinal TB. 
ENDOSCOPY 
The endoscopic findings from the esophagus, stomach and duodenum were reviewed  
In the stomach, endoscopic findings from both the fundus/body and antrum/incisura 
were documented separately. The various parameters recorded were the presence or 
absence of erosions, ulcerations, edema, erythema, nodularity, deformity, thickening, 
submucosal nodules and ulcero-proliferative growth. 
MICROSCOPY 
The 20 TB cases included 6 esophageal, 17 gastric and 12 duodenal mucosal biopsies. 
All the 20 CD cases had gastric biopsies (total number of 24 sites) and 16 had biopsies 
from duodenum. The CD cases had no esophageal mucosal biopsies 
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The H&E slides were retrieved from the archives, re stained when necessary and the 
histological parameters were assessed and entered into the database. The following 
features were assessed in all three locations 
 Chronic inflammation – The increase in the number of chronic inflammatory 
cells in the lamina propria as compared to the normal inflammatory infiltrates 
in each mucosal biopsy was evaluated and classified subjectively by a three tier 
system into mild, moderate and marked inflammation. 
 Focally enhanced inflammation – A lesion wherein one foveolus or small 
clusters of foveolae/ gastric glands were surrounded by a sharply demarcated 
inflammatory infiltrate, predominantly composed of lymphocytes, histiocytes 
and few granulocytes, with the epithelium occasionally infiltrated by 
inflammatory cells  
  Activity – The measure of disease activity based on neutrophilic infiltration of 
the epithelium and lamina propria in each biopsy was classified as mild, 
moderate and marked.  
 Presence of erosions (involving part of the mucosal thickness) and ulceration 
(full mucosal thickness). 
 Lymphoid aggregates – The presence and number of lymphoid aggregates in 
each biopsy was recorded. The number of lymphoid aggregates with germinal 
centers was also noted. 
 Fibrosis 
 Granulomas – An epithelioid cell granuloma was defined as ‘a discrete 
collection of at least five epithelioid cells which are activated histiocytes with 
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homogenous eosinophilic cytoplasm and elongated slipper shaped nuclei, with 
or without accompanying multinucleated giant cells’. 
The maximum diameter of the granulomas was measured using an ocular 
graticule in a standard Olympus microscope at 400x magnification. At this 
magnification, one unit of graticule measured 2.5 micrometre. 
Granulomas were classified as ‘small’, ‘medium’ and ‘large’ based on whether 
they were less than 200µm, 200-400µm  or >400µm in maximum dimension. 
Other parameters recorded for each granuloma included number, location, 
presence of a surrounding cuff, presence of necrosis, caseation, acid fast bacilli 
and organisation.  
Granulomas were considered ‘well organised’ if they were well contoured with 
the histiocytes oriented circumferentially around the centre. They were 
considered ‘loose/disorganised’ if the histiocytes were loosely arranged with 
poorly demarcated outlines. 
Granulomas were labelled as confluent when the boundaries of adjacent 
granulomas merged with each other. 
Caseation was defined as structureless necrosis with karyorrhetic debris. 
Histiocytic aggregates were defined as relatively small, loosely arranged 
collections of histiocytes without the other features of activation seen in 
epithelioid histiocytes. 
Each biopsy had a unique identification number assigned at the time it was received in 
the Department of Pathology. The biopsies of TB and CD were jumbled at the start of 
the study. Each case was then reviewed and data entered against biopsy numbers. 
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Only after all the biopsies were seen, was the final diagnosis matched to each case and 
the data analysed. This ensured that the pathologists were blinded to the diagnosis at 
the time of reviewing the slides. 
Statistical methods 
Categorical variables were summarised using counts and percentages. Quantitative 
variables were summarised using mean and standard deviation or median and 
range.  Chi square test was used to compare the proportions between the groups and 
two sample t tests were used to compare the means between the two groups. For non-
normal variables, Mann-Whitney U test was carried out. For all the analysis, 5% level 
of significance was considered to be significant. Software STATA version 13.1 for 
Windows was used for the statistical analysis. 
  
  
 
 
 
 
 
 
 
 
RESULTS 
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Forty cases with granulomatous inflammation in mucosal biopsies from the upper 
gastrointestinal tract that included 20 cases with a final diagnosis of Tuberculosis and 
20 cases with a final diagnosis of Crohn’s disease were studied. 
PATIENT DEMOGRAPHICS 
The median age of patients with TB was 27 years (range 4-56 years) with the peak 
incidence in the third decade. In the patient population with Crohn’s disease, the 
median age was 17 years (range 5-55 years) with the peak incidence in the second 
decade.  
The male: female ratio was 1.2:1 for TB and 3:1 for CD. 
 
Figure 1:  Age distribution of TB and CD patients. 
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CLINICAL DATA 
Among the 20 patients with TB, the clinical symptoms were unavailable for one 
patient. The remaining 19 patients presented with symptoms for a median duration of 
4 months (1-36 months). The patients with CD were clinically symptomatic for a 
median duration of 9 months (range1-48 months).  
The salient clinical features of all the cases are outlined in Table 1. 
Many features such as abdominal pain, loss of weight, loss of appetite and fever were 
prevalent to a similar extent in both the diseases.  However, dyspepsia as a presenting 
symptom was more common in TB (53%) as compared to CD (10%). Another 
significant difference noted was that almost 70% of CD patients presented with 
diarrhoea, while none of TB patients had diarrhoea.  
Evidence of extra-intestinal TB was identified in six of the TB patients. Amongst 
these, 4 patients had tuberculous lymphadenopathy (omental, cervical and axillary), 
one patient had hepatic TB and one had pulmonary TB.  
Six (30%) of the CD patients were detected to have fistula in ano at the time of 
presentation. One patient with CD was also diagnosed with uveitis.  
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Table 1 - Salient clinical features of all patients 
No. of cases with 
available clinical data  
TB (n=19) CD (n=20) p value  
 Dyspepsia 10 (52.63%) 2 (10%) 0.004 
Vomiting 8 (42.1%) 5 (25%) 0.257 
Hematemesis 1 (5.2%) 0  0.299 
Altered bowel habits 1 (5.2%) 0  0.299 
Diarrhoea 0 14 (70%) 0.0001 
Melena 0 2 (10%) 0.157 
Haematochezia 0 1 (5%) 0.323 
Loss of weight 11 (57.8%) 17 (85%) 0.060 
Loss of appetite 6 (31.57%) 9 (45%) 0.389 
Abdominal pain 11 (57.89%) 15 (75%) 0.257 
Dysphagia 3 (15.7%) 0 0.0644 
Early satiety 2 (10.5%) 0 0.1363 
Fever 3 (15.7%) 8 (40%) 0.0931 
Fistula in ano 0 6 (30%) 0.0094 
Extra-intestinal TB 6 (31.57%) 0 0.0063 
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INVESTIGATIONS 
Blood borne viruses 
Two of the TB patients were identified to have hepatitis B and one patient was 
positive for HIV. All the CD patients tested negative for blood borne viruses. 
ESR and CRP 
ESR values were available for only 8 of the 20 TB cases and median ESR was 56mm 
(range 3-120mm). Six of these eight TB patients had an elevated ESR of >20mm. Of 
the 20 CD cases, ESR values were available for 19 cases and the median ESR was 
60mm (range 9-105mm). 79% of the CD patients (15 patients) were detected to have 
an ESR of >20mm. 
 
Figure 2: Distribution of ESR (in mm) in TB and CD patients. 
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Only six of the 20 TB patients had available CRP values and the median CRP was 
18.90 (range 3.45-97.5). Of these six patients, four had an elevated CRP. CRP values 
were available for 18 of the 20 CD cases and the median CRP was 27.75 (range 3.30-
109).  Approximately 70% of the CD patients had an elevated CRP at the time of 
presentation. 
There was no significant difference in the distribution of ESR and CRP amongst the 
TB and CD patients. 
 
Figure 3: Distribution of CRP values in TB and CD patients 
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were positive in 3 of these cases.  Of the ten TB cases wherein Xpert TB PCR results 
were available, 2 cases were reported as positive. 
TB culture, QuantiFERON-TB GOLD assay and Xpert TB PCR were negative in all 
CD cases. 
RADIOLOGY 
The radiological investigation data were available only for 13 TB cases and 10 CD 
cases. The salient radiological features are enlisted in Table 2. 
Table 2 - Radiological features of 13 TB cases and 10 CD cases. 
 TB (n=13) CD (n=10) p value 
Esophageal abnormality 0 0 - 
Stomach abnormality 1 (7.6%) 0 0.370 
Duodenal abnormality 3 (23.08%) 0 0.103 
Lymphadenopathy 9 (69.23%) 3 (30%) 0.062 
Lung lesions 1 (7.6%)  0 0.370 
Ileo-caecal involvement 0 8 (80%) 0.0001 
Liver lesions 3 (23.07%) 0 0.103 
Spleen lesions 2 (15.38%) 0 0.194 
 
Esophageal involvement was not radiologically detected in both TB and CD cases. 
One TB case showed radiological gastric involvement and duodenal involvement was 
detected in 3 TB cases. Radiologically, none of the CD cases showed any gastric or 
duodenal abnormalities. 
An important observation noted was that, 70% of TB cases showed radiological 
evidence of lymphadenopathy as compared to the 30% in CD cases. 
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Table 3 - Distribution of lymphadenopathy in TB and CD. 
No. of cases with 
available radiological 
data 
TB (n=13) CD (n=10) p value 
Necrosis 7 (53.85%) 0 0.005 
Peri-esophageal 2 (15.38%) 0 0.194 
Peri-gastric 1 (7.69%) 0 0.369 
Periduodenal 0 0 - 
Lesser omental 4 (30.77%) 0 0.054 
Greater omental 4 (30.77%) 0 0.054 
Mesenteric  6 (46.15%) 3(30%) 0.431 
Para-aortic 5 (38.46%) 0 0.027 
 
Necrotic lymphadenopathy was noted in ~54% TB cases whereas necrosis was absent 
in all of the CD cases. This difference was found to be statistically significant with a 
p-value of 0.005.  In TB, lymph nodes from peri-esophageal, peri-gastric, lesser 
omentum, greater omentum, para-aortic and mesenteric regions were involved. 
However, in CD only the mesenteric lymph nodes were involved. 
Another striking observation was that radiological ileo-caecal involvement, 
predominantly in the form of wall thickening, was detected in 80% of CD cases 
whereas this finding was absent in all TB cases.  This difference was found to be 
statistically significant with a p-value of 0.0001.   
Furthermore, 3 TB cases showed radiological evidence of liver lesions and splenic 
lesions were reported in 2 TB cases. 
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UPPER GASTROINTESTINAL ENDOSCOPY 
Abnormal endoscopic findings were significantly more common (p value=0.014) in 
TB as compared to CD. Nineteen of the 20 TB cases (95%) had endoscopic 
abnormalities. Interestingly, in contrast, 10 of 20 CD cases (50%) were normal 
endoscopically. 
 
Figure 4: Proportion of cases with abnormal endoscopic findings. 
 
Table 4 - Distribution of cases with abnormal endoscopy findings in esophagus, 
fundus/body, antrum/incisura and duodenum 
Number of cases TB (n=20) CD (N=20) p value 
Esophagus 7 (35%) 0 0.0036 
Stomach 10 (50%) 8 (40%) 0.7512 
Fundus/Body 3 (15%) 2 (10%)  
Antrum/Incisura 5 (25%) 6 (30%)  
Both 2 (10%) 0  
Duodenum 11 (55%) 5 (25%) 0.053 
 
Esophagus – On endoscopy, seven of the TB cases demonstrated abnormal 
esophageal findings. In four of these cases (20%), the esophagus was involved in 
isolation. However, the esophagus was spared in all the CD cases. This difference was 
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Among the TB cases, the middle third of the esophagus was the site most frequently 
involved (5 of the 7 endoscopically abnormal esophageal cases).  The most common 
esophageal endoscopic finding in TB was ulceration (30%). The ulcerations were 
generally single in number, with a median size of 0.87cm (range 0.4-2.5cm). Other 
esophageal endoscopic findings documented in TB were erosions, edema, erythema, 
nodularity and ulcero-proliferative growth. 
Fundus/Body - Five of the TB cases (25%) and 2 CD cases (10%) had abnormal 
endoscopic findings in the fundus/body.   
Table 5 - Proportion of various abnormal endoscopic findings in fundus/body (n=Total number 
of cases) 
 
Total number of cases TB=20 CD=20 p value 
Erosions 1 (5%) 1 (5%) 1.00 
Edema 4 (20%) 1 (5%) 0.151 
Erythema 1 (5%) 2 (10%) 0.548 
Thickening 1 (5%) 0 0.311 
Submucosal nodules 2 (10%) 0  0.146 
 
Erosions, erythema and edema were seen in both TB and CD. However, edema was 
seen in 20% of TB cases as compared to the 5% in CD. Thickening and submucosal 
nodules were seen in one TB case each. 
Antrum/Incisura: Seven of the TB cases (35%) and 6 CD cases (30%) had abnormal 
endoscopic findings in the antrum/incisura.   
Table 6 - Proportion of various abnormal endoscopic findings in antrum/incisura (n=Total 
number of cases) 
Total number of cases TB=20 CD=20 p value 
Erosions 2 (10%) 3 (15%) 0.632 
Ulcerations 3 (15%) 1 (5%) 0.292 
Edema 3 (15%) 1 (5%) 0.292 
Erythema 1 (5%) 3 (15%) 0.292 
Thickening 0 1 (5%) 0.311 
Ulcero-proliferative 
growth 
1 (5%)   0 0.311 
Deformed pylorus 3 (15%) 1 (5%) 0.292 
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Erosions, ulcerations, edema, erythema and deformed pylorus were the common 
findings reported in both TB and CD cases with no significant statistical difference in 
their prevalence. 
Duodenum:  Abnormal duodenal endoscopic findings were significantly more 
common (p value=0.05) in TB (55%) as compared to CD (25%) cases. In both the TB 
(45%) and CD (60%), the second part of the duodenum was the site most frequently 
involved. 
Table 7- Proportion of various abnormal endoscopic findings in duodenum (n=Total number of 
cases) 
Number of cases TB=20 CD=20 p value 
Erosions 3 (15%) 1 (5%) 0.292 
Ulcerations 2 (10%) 1 (5%) 0.548 
Edema 5 (25%) 1 (5%) 0.077 
Erythema 3 (15%) 2 (10%) 0.635 
Nodular mucosa 4 (20%) 2 (10%) 0.375 
Thickening 1 (5%) 1 (5%) 1.00 
Deformed duodenum 4 (20%) 1 (5%) 0.152 
Granularity 1 (5%) 0 0.312 
 
Erosions, ulcerations, nodular mucosa, thickening, erythema and edema were the 
common findings reported in both TB and CD cases with no significant statistical 
difference in their prevalence. However, edema was slightly more common in TB 
(25%) as compared to CD (5%).  
Correlation of upper GI endoscopy with lower GI endoscopy and histology 
Among the 20 TB cases, lower GI endoscopy data was available for only 4 patients.  
Ironically, the only case with an endoscopically normal upper GI endoscopy had a 
corresponding abnormal lower GI endoscopy, moderate chronic inflammation and 
granulomatous inflammation. Among the 19 cases with an endoscopically abnormal 
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upper GI, lower gastrointestinal details were available for only 3 cases and all these 
three cases had an endoscopically normal lower GI, no significant chronic 
inflammation or granulomatous inflammation 
Among the 10 CD cases wherein upper GI endoscopy was normal, 80% of them had 
an abnormal lower GI endoscopy, and 60% cases each had lower GI moderate chronic 
inflammation and granulomatous inflammation. Of the CD cases with abnormal upper 
GI endoscopy, lower GI data was unavailable for one case and among the remaining 9 
cases, 66% has a corresponding abnormal lower GI endoscopy, 22% had lower GI 
moderate chronic inflammation and 55% had granulomatous inflammation. 
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HISTOLOGICAL FEATURES 
STOMACH 
Of the 20 TB cases, only 11 cases had at least one gastric biopsy for assessment. 
However, all the 20 CD cases had at least one gastric biopsy for evaluation. 
The 11 TB cases together had 17 gastric biopsies and the 20 CD cases had 24 gastric 
biopsies. The various histological parameters were studied and contrasted between the 
17 TB gastric biopsies and the 24 CD gastric biopsies. 
Chronic inflammation – TB cases (47%) had a higher prevalence of moderate chronic 
lamina propria inflammation as compared to CD (29%). However, this difference was 
not statistically significant. The inflammation extended to the deeper mucosa in up 
95% of TB cases. In 21% of CD cases, the inflammation was restricted to the 
superficial parts of the mucosa (Table 10). 
 Patchy/discontinuous inflammation was present in an equal frequency in both TB and 
CD (Table 11). 
Fibrosis - Fibrosis was significantly higher in TB biopsies (82.35%) as compared to 
CD biopsies (41.67%). The difference was statistically significant with a p value of 
0.009. 
Lymphoid aggregates - Interestingly, the presence of lymphoid aggregates was also 
more common in TB biopsies (70%) in contrast to the CD cases (33.33%).  This 
difference was also proved to be significant statistically with a p value of 0.019. 
However, the median number of lymphoid aggregates per biopsy was not significantly 
different between TB and CD. 
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Table 8 – Salient histological features in TB and CD gastric mucosal biopsies. 
 
Number of gastric biopsies TB (n=17) CD (n=24) p value 
Mean number of fragments 2.47 2.75  
Mean number of low power 
fields 
2.76 3  
Severity of lamina propria 
chronic inflammation 
   
Mild 9 (52.94%) 17 (70.83%) 0.328 
Moderate 8 (47.06%) 7 (29.17%) 0.328 
Fibrosis 14 (82.35%) 10 (41.67%) 0.009 
Lymphoid aggregates    
Present 12 (70.59%) 8 (33.33%) 0.019 
Median number, range 2 (1-6) 2 (1-2) 0.128 
Intestinal metaplasia 2 (11.76%) 1 (4.17%) 0.357 
Foveolar hyperplasia    
None 2 (11.76%) 3 (12.50%) 0.771 
Mild 14 (82.35%) 18 (75%)  
Moderate 1 (5.88%) 3 (12.50%)  
Glandular atrophy    
None 4 (23.52%) 8 (33.33%) 0.033 
Mild 7 (41.18%) 15 (62.5%)  
Moderate 6 (35.29%) 1 (4.17%)  
Focally enhanced gastritis 5 (29.41%) 15(62.5%) 0.039 
Distribution of FEG    
Perifoveolar 3 (17.64%) 9 (62.5%) 0.0137 
Periglandular 2 (11.76%) 3 (12.5%) 0.944 
Both 1 (5.88%) 3 (12.5%)  
Foveolitis 10 (58.82%) 19 (79.17%) 0.1584 
Severity of foveolitis    
Mild 5 (29.41%) 15 (62.5 %) 0.112 
Moderate 5 (29.41%) 4 (18.18%)  
Foveolar abscess 5 (29.41%) 1 (8.33%) 0.0772 
Erosion 0 2(8.33%) 0.2223 
Ulceration 2(11.76%) 1(4.17%) 0.357 
Lamina propria neutrophils    
None 6 (35.29%) 2 (8.33%) 0.015 
Mild 6 (35.29%) 19 (79.17%)  
Moderate 5 (29.41%) 3 (12.5%)  
Helicobacter pylori 
 
2 (11.76%) 
 
4 (16.67%) 
 
0.662 
 
Histiocytic aggregates 1 (5.88%) 0 0.22 
Granulomatous inflammation 10 (58.82%) 21 (87.5%) 0.0352 
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Table 9 - Extent of lamina propria chronic inflammation. 
No. of gastric biopsies TB(n=17) CD(n=24) p value 
Superficial 1 (5.89%) 5 (20.83%) 0.182 
    
Both superficial and 
deep 16 (94.11%) 19 (79.17%) 
 
 
Table 10- Distribution of lamina propria inflammation – Patchy/Diffuse 
No. of gastric biopsies TB(n=17) CD(n=24) p value 
Patchy/Discontinuous 5 (29.41%) 7 (29.17%) 0.986 
    
Diffuse 12 (70.59%) 17 (70.83%)  
 
Focally enhanced gastritis was a statistically significant finding in CD cases (62.5%) 
in contrast to TB. However, it must be emphasized that the entity of focally enhanced 
gastritis was also noted in 5% of TB biopsies, thereby highlighting that this finding is 
not exclusive to CD.  
Focally enhanced gastritis in CD biopsies (62.5%) had a predominant perifoveolar 
distribution in contrast to TB biopsies (23.53%). This difference was statistically 
significant with a p value of 0.013. 
The prevalence of foveolar hyperplasia was similar in TB and CD. However, the 
prevalence of moderate glandular atrophy was significantly higher in TB (35%), 
unlike CD wherein majority of the cases had mild glandular atrophy (62%). 
CD biopsies (79%) had a higher prevalence of foveolitis and foveolar mucin depletion 
in contrast to the 59% in TB biopsies. However, moderate foveolitis was significantly 
higher in TB (30%), in contrast to CD wherein majority of the cases had mild 
foveolitis (62%).  Foveolar abscess formation was also more prevalent in TB (29%) as 
compared to CD (8.33%). 
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Ulcerations were present in 2 TB gastric biopsies, of which one biopsy had histiocytic 
aggregates, epithelioid granulomas and palisading histiocytes within the ulcer base. 
The prevalence of moderate lamina propria activity was significantly higher in TB 
(29.41%), unlike CD wherein majority of the cases had mild activity (79.17%). This 
difference was statistically significant with a p value of 0.015. 
Granulomatous inflammation:  
Granulomatous inflammation was present in 58% of TB biopsies (10 of 17) and 
87.5% of the CD gastric biopsies (21 of 24 cases). Majority of the CD gastric biopsies 
(22 of 24) were taken from the antrum with only few fundus/body biopsies (2 of 24). 
Due to this uneven distribution of biopsies, the exact prevalence of granulomatous 
inflammation between TB and CD in different parts of the stomach could not be 
assessed. 
Table 11 - Number of epithelioid granulomas and presence of discrete/confluent 
granulomas. 
Number of gastric biopsies 
with granulomatous 
inflammation 
TB (n=10) CD (n=21) p value 
Median number of 
epithelioid granuloma 
4.5 
(1-11) 
1 
(1-3) 
0.003 
Median number of 
epithelioid  
granulomas/fragment 
1.75 
(0.5-5.5) 
0.5 
(0.12-0.15) 
0.008 
Median number of 
epithelioid  granulomas/low 
power field 
1.41 
(0.5-3.67) 
0.5 
(0.14-3) 
0.005 
Discrete/Confluent/Both    
Discrete 4 (40%) 21 (100%) 0.0004 
Confluent  1 (10%) 0  
Both 5 (50%) 0  
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The median number of epithelioid granulomas/ biopsy were significantly higher in TB 
biopsies with a median of 4.5 granulomas (range 1-11) in contrast to CD biopsies with 
a median of one granuloma per biopsy (range 1-3). This was a statistically significant 
difference with a p value of 0.003. 
Similarly, the number of epithelioid granulomas per fragment as well as the number of 
epithelioid granulomas per low power field is also significantly higher in TB biopsies 
All the granulomas in CD biopsies were discrete granulomas. However, in TB 
biopsies both discrete and confluent granulomas were observed. This difference was 
statistically significant with a p value of 0.0004 
 
 
                                                                                                                              
            Tuberculosis     Crohn’s disease 
Figure 5: Proportion of biopsies with granulomatous inflammation in body/fundus and 
antrum/incisura. 
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Table 12 – Characteristics of granulomas in the 11 TB and 20 CD cases which have at least one 
gastric biopsy 
No. of cases with at least one 
gastric biopsy. 
TB (n=11) CD (n=20) p value 
Granulomatous inflammation 
present 
8 (72.73%) 19 (95%) 0.4079 
≥4 granulomas 
 
 
4 (36.36%) 
 
 
0 
 
 
0.0039 
At least one large granuloma 
 
3 (27.27%) 
 
 
0 
 
 
0.0140 
At least one disorganised 
granuloma 
 
 
4 (36.36%) 
 
 
 
12 (60%) 
 
 
 
0.2077 
All compact granulomas 
 
 
 
4 (36.36%) 
 
 
 
7 (35%) 
 
 
 
0.9395 
At least one granuloma with 
lymphoid cuff 
 
 
8 (72.73%) 
 
 
 
10 (50%) 
 
 
 
0.2198 
At least one granuloma with giant 
cells 
 
3 (27.27%) 
 
 
9(45%) 
 
 
0.3323 
At least one granuloma with 
necrosis 
 
1 (9.09%) 
 
 
0 
 
 
0.171 
At least one perifoveolar 
granuloma 
 
0 
 
 
4 (20%) 
 
 
0.112 
At least one periglandular 
granuloma 
 
 
1 (9.09%) 
 
 
 
2 (10%) 
 
 
 
0.935 
At least one granuloma with AFB 
 
1 (9.09%) 
 
0 
 
0.171 
 
Table 12 enlists the salient features of the granulomatous inflammation in the 11 TB 
cases and 20 CD cases which have at least one gastric biopsy. The significant findings 
observed were that ≥4 granulomas (36% vs 0) and large granuloma (27% vs 0) were 
more common in TB as compared to CD. The presence of at least one disorganised 
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granuloma was more common in CD (35%). Necrosis, caseation or the presence of 
acid fast bacilli was not a significant finding in both TB and CD. 
Table 13 – Characteristics of individual granulomas in patients with gastric 
tuberculosis (TB) and Crohn’s disease (CD) 
Total number of 
granulomas 
TB (n=49) CD (n=29) p value 
Median maximum diameter 207.5 µm 125 µm   
Smallest diameter 100 µm 50 µm  
Largest diameter 600 µm 275 µm  
Size    
Small 24 (48.98%) 24 (82.76%) 0.0072 
Medium 18 (36.73%) 5 (17.24%)  
Large 7 (14.29%) 0  
Location     
Ulceration 3 (6.12%) 0 0.016 
Superficial 7 (14.29%) 13 (44.83%)  
Deep 32 (65.30%) 12 (41.38%)  
Both superficial and deep  
3 (6.12%) 
 
4 (13.79%) 
 
Submucosa 3 (6.12%) 0  
Not estimable 1 (2%) 0  
Disorganised/Compact    
Disorganised 8 (16.33%) 19 (65.52%) 0.0001 
Compact 41 (83.67%) 10 (34.48%)  
Lymphoid cuff 46 (93.87%) 12 (41.38%) 0.0001 
Giant cells 7 (14.29%) 12 (41.38%) 0.0071 
Necrosis 5 (10.20%) 0 0.0754 
Acid fast bacilli 1 (2.04%) 0 0.439 
Perifoveolar 0 4 (13.79%) 0.0076 
Periglandular 1 (2.04%) 2 (6.90%) 0.281 
 
 
In TB, the median maximum diameter of a granuloma was 207.5 µm with the smallest 
granuloma measuring 100 µm and the largest granuloma measuring 600 µm.  In 
contrast in CD, the median maximum diameter was 125 µm, smallest diameter was 
50µm and largest diameter was 275 µm. 
Majority of the CD granulomas (82.76%) were small in size as compared to TB 
granulomas. Medium and large granulomas constitute almost 50% of TB granulomas, 
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in contrast to only 18% in CD granulomas. This difference was statistically significant 
with a p value of 0.007. 
TB granulomas were more commonly located within ulcerations and in the 
submucosa.  
Other significant observations include the higher prevalence of compact granulomas 
(83%) and granulomas with lymphoid cuff (46%) in TB. Disorganised granulomas 
and perifoveolar granulomas were significantly more common in CD (13.79%). 
 
 
 
 
 
 
 
 
 
 
 
 
54 
 
Endoscopic correlation 
Table 14 – Comparison of salient histological features between endoscopically normal 
and abnormal gastric mucosa in both TB and CD. 
Total number 
of cases with 
gastric biopsies 
11 TB cases 20 CD cases 
Endoscopy 
Normal (3) 
Endoscopy 
Abnormal (n=8) 
Endoscopy Normal 
(13) 
Endoscopy Abnormal 
(n=7) 
Focally 
enhanced 
gastritis present 
3 (100%) 2 (25%) 9 (69.23%) 4 (57.14%) 
Moderate 
chronic 
inflammation 
0 (%) 4 (50%) 2 (18.18%) 5 (71.43%) 
Granulomatous 
inflammation 
present 
3 (100%) 5 (62.5%) 12 (92.30%) 7 (100%) 
 
The endoscopically normal gastric biopsies were compared with endoscopically 
abnormal gastric biopsies for various parameters for both TB and CD 
Three of 11 TB cases had endoscopically normal mucosa. Strikingly, these cases also 
had histological changes like focally enhanced gastritis and granulomatous 
inflammation. The prevalence of moderate chronic inflammation in TB cases was 
higher in endoscopically abnormal mucosa. 
Of the 20 CD cases, the 13 cases which had an endoscopically normal mucosa had a 
high frequency of focally enhanced gastritis (69%) and granulomatous inflammation 
(92%). The prevalence of moderate chronic inflammation in CD cases was 
significantly higher in endoscopically abnormal mucosa (71.43%). 
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DUODENUM 
Of the 20 TB and 20 CD cases included in our study, the various histological 
parameters were studied and contrasted between the 12 TB and 16 CD cases which 
had duodenal biopsies.  
Table 15 - Salient histological features in TB and CD duodenal mucosal biopsies. 
 
Number of cases with duodenal 
biopsies 
TB (n=12) CD (n=16) p value 
Crypt villous alteration with 
villous atrophy 
   
Absent 4 (33.33%) 13 (81.25%) 0.036 
Mild 6 (50%) 2 (12.50%)  
Moderate 2 (16.67%) 1 (6.25%)  
Increased IELs 3 (25%) 2 (12.5%) 0.392 
Severity of lamina propria 
chronic inflammation 
   
Mild 7 (58.33%) 15 (93.75%) 0.073 
Moderate 5 (41.66%) 1 (6.25%)  
Lymphoid aggregates 8 (66.67%) 4 (25%) 0.027 
Cryptitis 4 (33.33%) 3 (18.75%) 0.378 
Crypt hyperplasia 9 (75%) 8 (50%) 0.180 
Brunner’s gland hyperplasia 6 (50%) 4 (25%) 0.277 
Pyloric metaplasia 3 (25%) 1 (6.25%) 0.161 
Fibrosis 5 (41.67%) 5 (31.25%) 0.569 
Surface neutrophilic infiltration 5 (41.67%) 5 (31.25%) 0.569 
Lamina propria neutrophils    
Absent 6 (50%) 12 (75%) 0.174 
Mild 6 (50%) 3 (18.75%)  
Moderate 0 1 (6.25%)  
Erosions 3 (25%) 0 0.034 
Ulceration 1 (8.33%) 0 0.240 
Granulomatous inflammation 7 (58.23%) 1 (6.25%) 0.0025 
 
Of the 12 TB cases, crypt villous ratio alteration and villous atrophy was seen in 8 
cases (50% mild, 16% moderate). However, in CD cases, crypt villous ratio alteration 
and villous atrophy was observed in only 3 cases. This difference was statistically 
significant with a p value of 0.036. 
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Figure 6:  Distribution of intraepithelial lymphocytes 
 
 
25% of TB cases and 12.5% of CD cases had increased intraepithelial lymphocytes. 
The distribution of IELs is diagrammatically represented in Figure 6. In both TB and 
CD, majority of the patients had an IEL count of <25 and there was no significant 
statistical difference. 
The prevalence of moderate chronic inflammation was significantly higher in TB 
(41.66%) in contrast to CD (6.25%). In CD, the majority of cases only had mild 
inflammation (93.75%) 
The presence of lymphoid aggregates was strikingly more common in TB biopsies 
(66.67%) in contrast to the CD cases (25%).  This difference was also proved to be 
significant statistically with a p value of 0.027. 
The prevalence of cryptitis, crypt hyperplasia, Brunner’s gland hyperplasia, pyloric 
metaplasia and surface neutrophilic infiltration was higher in TB as compared to CD, 
however, these differences were not statistically significant. 
Lamina propria activity was seen more in TB cases as compared to CD. Also, 3 of the 
TB cases had erosions, however erosions were absent in all of the CD cases. 
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Granulomatous inflammation - Granulomatous inflammation was more frequent in 
TB than CD. Only 6.25% of CD cases had granulomatous inflammation as compared 
to the 58.3% TB cases. This difference was statistically significant with a p value of 
0.0025.   
Table 16 - - Number of epithelioid granulomas and presence of discrete/confluent 
granulomas. 
Number of biopsies with 
granulomatous inflammation 
TB (n=7) CD (n=1) p value 
Median number of epithelioid 
granuloma 
1 
(1-5) 
1 
(1-1) 
0.7055 
Median number of epithelioid  
granulomas/fragment 
0.50 
(0.14-1) 
0.25 
          (0.25-0.25) 
 
0.4966 
Median number of epithelioid  
granulomas/low power field 
0.33 
(0.14-1) 
 
0.33 
(0.33-0.33) 
 
0.8220 
Discrete/Confluent/Both    
Discrete 6 (85.71%) 1 (100%) 0.686 
Confluent 0 0  
Both 1 (14.29%) 0  
 
The median number of granulomas was one in both TB and CD. However, the 
maximum number of granulomas in TB duodenal biopsies was more (up to 5) as 
compared to CD duodenal biopsies. 
In both TB and CD, the granulomas were predominantly discrete. 
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Figure 7 Distribution of location of granulomatous inflammation 
 
In TB, granulomatous inflammation was more common in biopsies from the first part 
of duodenum. The single CD case with duodenal granulomatous inflammation was 
from the second part of the duodenum. 
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Table 17 – Characteristics of granulomas in the 12 TB and 16 CD cases which have at least one 
duodenal biopsy 
No. of cases with duodenal biopsies TB(n=12) CD(n=16) p value 
Granulomatous inflammation 
 
7 (58.33%) 
 
1 (6.25%) 
 
 
0.0025 
 
≥4 granulomas 
 
 
1 (8.33%) 
 
 
0 
 
 
 
0.2396 
 
 
At least one large granuloma 
 
2 (16.67%) 
 
 
0 
 
 
0.0901 
 
At least one disorganised granuloma 
 
 
1 (8.33%) 
 
 
0 
 
 
 
0.2396 
 
 
All compact granulomas 
 
 
6 (50%) 
 
 
    1(6.25%) 
 
 
0.0082 
At least one granuloma with a lymphoid 
cuff 
 
 
6 (50%) 
 
 
 
1 (6.25%) 
 
 
 
0.0082 
At least one granuloma with giant cells 
 
 
7 (58.33%) 
 
 
0 
 
 
0.0004 
At least one granuloma with inclusion 
 
 
1 (8.33%) 
 
 
0 
 
 
0.2396 
At least one granuloma with necrosis 
 
 
1 (8.33%) 
 
 
0 
 
 
0.2396 
 
Table 17 enlists the salient features of the granulomatous inflammation in the 12 TB 
cases and 16 CD cases which have at least one duodenal biopsy. Duodenal mucosal 
biopsies with ≥4 granulomas, large granulomas, compact granulomas and granulomas 
with a lymphoid cuff were more frequent in TB as compared to CD.  Necrosis, 
caseation or the presence of acid fast bacilli was not a significant finding in both TB 
and CD. 
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Characterisation of granulomas 
Table 18 – Characteristics of individual granulomas in patients with duodenal 
tuberculosis (TB) and Crohn’s disease (CD) 
Total number of 
granulomas 
TB (n=11) CD (n=1) p-value 
Median maximum diameter 200 µm 212.50 µm   
Smallest diameter 115 µm   
Largest diameter 462.50 µm   
Size    
Small 5 (45.45%) 0 0.466 
Medium 4 (36.36%) 1 (100%)  
Large 2 (18.18%) 0  
Location     
Ulceration 0 0 0.460 
Villous 0 0  
Deep 7 (63.63%) 1 (100%)  
Submucosa 4 (36.37) 0  
Disorganised/Compact    
Disorganised 1 (9.09%) 0 0.753 
Compact 10(90.90%0 1 (100%)  
Lymphoid cuff 10 (90.91%) 1 (100%) 0.753 
Giant cells 6 (60%) 0 0.251 
Necrosis 1 (9.09%) 0 0.753 
Inclusion 1 (9.09%) 0 0.753 
Perifoveolar 0 4 (13.79%) 0.0076 
Periglandular 1 (2.04%) 2 (6.90%) 0.281 
 
In TB, the median maximum diameter was 200 µm with the smallest granuloma 
measuring 115 µm and the largest granuloma measuring 462.5 µm. In CD, the only 
granuloma present had a maximum diameter of 212.50 µm. 
TB granulomas were more commonly located in the deep mucosa and submucosa. 
Another significant observation was the higher prevalence of compact granulomas 
(90%) in TB. 
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Endoscopic correlation 
Table 19 - Comparison of histological features between endoscopically normal and  
abnormal duodenal mucosa in both TB and CD. 
Total number 
of cases with 
duodenal 
biopsies 
12 TB cases 16 CD cases 
Endoscopy 
Normal (2) 
Endoscopy 
Abnormal (n=10) 
Endoscopy Normal 
(11) 
Endoscopy 
Abnormal (n=5) 
Altered Crypt 
villous ratio 
0 8 (80%) 1 (9.09%) 3 (60%) 
Moderate 
chronic 
inflammation 
0  5 (50%) 0 1 (20%) 
Granulomatous 
inflammation 
present 
0 7 (70%) 0 1 (20%) 
 
The endoscopically normal duodenal biopsies were compared with those from 
endoscopically abnormal duodenal biopsies for various histological parameters in both 
TB and CD. The duodenal biopsies with normal endoscopy in both TB and CD 
correlated with a normal histological picture. Endoscopically abnormal duodenal 
biopsies were associated with a higher prevalence of altered crypt ratio, moderate 
chronic inflammation and granulomatous inflammation in both TB and CD. 
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ESOPHAGUS 
Only six of the 20 TB cases had esophageal biopsies, while none of the 20 CD cases 
had esophageal biopsies. Therefore, the histological parameters were studied and 
analysed for only the six TB esophageal biopsies.  
Table 20 - Salient histological feature of esophageal TB. 
Number of esophageal biopsies Number of cases Percentage 
Ulceration 5  83.33%  
Parakeratosis 2 33.33% 
Basal cell hyperplasia 3 50% 
Papillary elongation 3 50% 
Papillary congestion 3 50% 
Acanthosis   
Absent 3 50% 
Mild 1 16.67% 
Moderate 1 16.67% 
Cannot be assessed 1 16.67% 
Intraepithelial lymphocytes 6 100% 
Severity of IELs   
Mild 4 83.33% 
Moderate 1 16.67% 
Marked 1 16.67% 
Location of the IELs   
Peripapillary 1 16.67% 
Interpapillary 0 0 
Both 5 83.33% 
Intraepithelial eosinophils 1 16.67% 
Severity of lamina propria chronic 
inflammation. 
  
Mild 1 16.67% 
Moderate 4 66.66% 
Marked 1 16.67% 
Severity of lamina propria activity   
Absent 1 16.67% 
Moderate 5 83.33% 
Fibrosis 4 66.67% 
Lymphoid aggregates 3 50% 
Granulomatous inflammation 6 100% 
 
The most common site of involvement within the esophagus in TB was the middle 
third (66%). One of the common findings was ulceration which was seen in 5 of the 6 
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TB esophageal biopsies (83.33%). The ulceration extended up to the submucosa in 
one of these cases, while in the others depth of the ulceration could not be assessed.  
Basal cell hyperplasia, papillary elongation and papillary congestion were present in 3 
of 6 TB esophageal biopsies (50%). Two cases had acanthosis and only one case had 
intraepithelial eosinophils.  
All the 6 cases had intraepithelial lymphocytes. The intraepithelial lymphocytes were 
predominantly located in both the peripapillary and interpapillary region (83.33%). In 
four of the cases, there was only a mild increase in IELs and only one case each had 
moderate and marked increase in IELs respectively. 
Five of the six cases had moderate to marked lamina propria chronic inflammation as 
well as moderate lamina propria activity (83%). 
Granulomatous inflammation 
Granulomatous inflammation was present in all the six cases. The median number of 
granulomas per biopsy was 3.5 (range 1-9).  The median number of epithelioid 
granulomas/fragment and number of epithelioid granulomas/ low power field is 0.55 
(0.08 - 1) and 0.14 (0.14 - 1.20) respectively. 
Table 21 – Median number of granulomas in esophageal TB. 
 
 
 
 
 Median, Range 
Number of epithelioid granulomas/ 
biopsy 
3.5  (1-9) 
Number of epithelioid granulomas/ 
fragment 
0.55  (0.08-1) 
Number of epithelioid granulomas/low 
power field 
0.63  
(0.14-1.20) 
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Table 22 – Salient features of granulomas in the 6 TB esophageal biopsies 
 
No. of cases with esophageal biopsies TB (n=6) 
  
≥4 granulomas 
 
6 (100%) 
 
At least one large granuloma 
 
3 (50%) 
 
At least one disorganised granuloma 
 
4(66.67%) 
 
All compact granulomas 
 
2 (33.33%) 
 
At least one with a lymphoid cuff 
 
 
5 (83.33%) 
 
 
At least one granuloma with giant cells 
 
6 (31.58%) 
 
At least one granuloma with necrosis 
 
3 (50%) 
 
 
All six cases had ≥4 granulomas. Three of the biopsies had at least one large 
granuloma and at least one granuloma with necrosis. Lymphoid cuff was present in 5 
of the cases and necrosis was present in 3 of the cases. 
Table 23 – Characteristics of individual granulomas in esophageal TB. 
 
Total number of granulomas (n=25)   
Median maximum diameter 250 µm 
Smallest diameter 132.50 µm 
Largest diameter 590 µm 
Size  
Small 10 (40%) 
Medium 12 (48%) 
Large 1 (12%) 
Location  
Lamina propria 9 (36%) 
Submucosa 6 (24%) 
Ulceration 10 (40%) 
Lymphoid cuff 8 (32%) 
Giant cells 9 (36%) 
Necrosis 5 (20%) 
Compact  16 (64%) 
 
65 
 
The 6 biopsies together had 25 granulomas. The median maximum diameter of these 
25 granulomas was 250 micrometres (range 132.50-590). 
60% of the granulomas were medium to large sized.. The granulomas were located in 
decreasing frequency within ulceration (40%), lamina propria (36%) and submucosa 
(24%). Majority of the granulomas were compact (64%) 
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Table 24 - Salient distinguishing features between upper GI tuberculosis (TB) and 
Crohn’s disease (CD). 
Total number of cases TB (n=20) CD (n=20) p value 
Moderate chronic 
inflammation 
11 (55%) 7 (35%) 0.203 
Focally enhanced 
gastritis 
5 (25%) 15 (75%) 0.0016 
Equal to or more than 4 
granulomas 
8 (40%) 0 0.0016 
At least one large 
granuloma 
6 (30%) 0 0.0079 
At least one 
disorganised granuloma 
6 (30%) 16 (80%) 0.0015 
Only discrete 
granulomas 
11 (55%) 20 (100%) 0.0007 
Only confluent 
granulomas 
9 (45%) 0 0.0007 
 
In the upper gastrointestinal tract, moderate inflammation was seen more commonly 
in TB as compared to CD, though this difference was not found to be statistically 
significant. Focally enhanced gastritis was a significant finding in upper GI CD. 
However, it must be emphasized that the entity of focally enhanced gastritis was also 
noted in 5% of TB biopsies, thereby highlighting that this finding is not exclusive to 
CD.  
With respect to granulomatous inflammation, biopsies with equal to or more than 4 
granulomas, large granulomas and confluent granulomas were seen more commonly 
in TB.  However, disorganised granulomas were seen more commonly in CD.
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Photomicrograph 1: Mild chronic inflammation with a single discrete granuloma in a 
case of Crohn's disease (H&E, 40X magnification). 
 
 
 
Photomicrograph 2: Moderate chronic inflammation in a case of Tuberculosis (H&E, 
40X magnification). 
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Photomicrograph 3: Focally enhanced gastritis in a case of Crohn's disease (H&E, 100X 
magnification). 
 
 
 
Photomicrograph 4: Focally enhanced gastritis in a case of Crohn's disease (H&E, 400X 
magnification). 
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Photomicrograph 5:  Patchy chronic inflammation in a case of Crohn's disease (H&E, 
40X magnification). 
 
 
 
Photomicrograph 6:   Presence of lymphoid aggregates in a case of Tuberculosis (H&E, 
40X magnification). 
 
70 
 
 
Photomicrograph 7:  Foveolitis and lamina propria activity in a case of Tuberculosis 
(H&E, 200X magnification). 
 
 
 
Photomicrograph 8: Foveolar abscess formation in a case of Tuberculosis (H&E, 200X 
magnification). 
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Photomicrograph 9: Intestinal metaplasia in a case of Tuberculosis (H&E, 100X 
magnification). 
 
 
 
Photomicrograph 10:  Preserved crypt villous ration in a case of Crohn's disease (H&E, 
40X magnification) 
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Photomicrograph 11: Mild villous atrophy with increase in intraepithelial lymphocytes 
in a case of Tuberculosis (H&E, 200X magnification). 
 
 
 
Photomicrograph 12: Increase in intraepithelial lymphocytes in a case of Tuberculosis 
(H&E, 400X magnification) 
 
73 
 
 
Photomicrograph 13: Cryptitis in a case of Tuberculosis, (H&E, 200X magnification). 
 
 
 
Photomicrograph 14: Esophageal mucosal biopsy with marked chronic inflammation 
(H&E, 40X magnification). 
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Photomicrograph 15: Esophageal mucosal biopsy with mild increase in intraepithelial 
lymphocytes (H&E, 200X magnification). 
 
 
 
Photomicrograph 16: Esophageal mucosal biopsy with moderate increase in 
intraepithelial lymphocytes (H&E, 200X magnification) 
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Photomicrograph 17: Gastric mucosal biopsy with four granulomas in a case of 
Tuberculosis (H&E, 40X magnification). 
 
 
 
Photomicrograph 18: Confluent granulomas (H&E, 40X magnification). 
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Photomicrograph 19: A discrete granuloma in a case of Crohn’s disease (H&E, 100X 
magnification) 
 
 
 
Photomicrograph 20: A small perifoveolar granuloma in a case of Crohn’s disease 
(H&E, 100X magnification). 
77 
 
 
Photomicrograph 21: A medium sized granuloma with lymphoid cuff in a case of 
Tuberculosis (H&E, 100X magnification). 
 
 
 
 
Photomicrograph 22: A large granuloma with necrosis in a case of Tuberculosis (H&E, 
100X magnification). 
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Photomicrograph 23: A disorganised granuloma in a case of Crohn's disease (H&E, 
100X magnification). 
 
 
 
Photomicrograph 24: Compact granulomas in a case of Tuberculosis (H&E, 100X 
magnification). 
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Photomicrograph 25: A granuloma with inclusions in a case of Tuberculosis (H&E, 
100X magnification). 
 
 
 
 
Photomicrograph 26: A granuloma with inclusions in a case of Tuberculosis (H&E, 
400X magnification). 
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Photomicrograph 27:  Duodenal mucosal biopsy with granulomatous inflammation in a 
case of Crohn's disease (H&E 100X magnification). 
 
 
 
Photomicrograph 28: Esophageal biopsy with a large submucosal granuloma in a case 
of Tuberculosis (H&E, 100X magnification).
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DISCUSSION 
 
The clinical and histological features in upper gastrointestinal Crohn’s disease has 
been studied and documented in the western population. There are very few case 
series of upper gastrointestinal Tuberculosis. Case reports are mostly from developing 
countries and describe the presence of granulomas as the sole criterion for the definite 
diagnosis of upper gastrointestinal TB. The associated mucosal changes in TB have so 
far not been described. Despite the increasing incidence of Crohn’s disease in our 
population, no studies have attempted to distinguish upper GI Tuberculosis from 
Crohn's disease nor have they documented the differences in characteristics of 
granulomas in upper gastrointestinal TB and CD.  
Age - In our study, the median age of the TB patients was 27 years (ranged  4- 56 
years) with a peak incidence in the third decade. Among the CD patients, the median 
age was 17 years (range 5-55 years) with the peak incidence in the second decade.  
This finding was similar to that demonstrated in studies by Mashako et al, Cameroon 
et al, Hardee et al and Tobin et al, wherein they had reported a higher incidence of 
upper gastrointestinal CD in adolescents and young adults (2,7,15,64).  
Clinical features - The total duration of symptoms in patients with a diagnosis of CD 
(9 months) was longer than that of TB patients (4 months). Previous published studies 
from our institute and studies by other authors comparing TB versus CD in the lower 
GIT  had shown a similar finding (70,74,75). 
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Clinical symptoms such as abdominal pain, loss of weight, loss of appetite and fever 
had a similar prevalence in both TB and CD. The only striking differences noted were 
that dyspepsia was more common in TB and diarrhoea, as a presenting symptom, was 
more common in CD . However, it is important to note that, patients with upper GI 
CD nearly always have concomitant lesions in the lower GIT and therefore it is 
difficult to determine whether the symptoms were solely due to the upper GI 
involvement(1). 
Radiology - On CT imaging, involvement of the upper GIT was rare to absent in both 
TB and CD. However, in our study, radiological evidence of lymphadenopathy was 
significantly more common in TB as compared to CD (p value-0.062). Also, necrotic 
lymph nodes were a significant finding in TB, as compared to CD where it was absent 
(p value – 0.005). In our study, the lymph node groups involved in TB only included 
peri-esophageal, peri-gastric, lesser omentum, greater omentum, mesenteric and para-
aortic lymph nodes. Further, mesenteric lymph nodes were more frequent in TB than 
CD in our study. 
Concomitant radiological ileo-caecal involvement was present in majority of CD 
cases. On the other hand, few of TB cases had concomitant liver and splenic lesions.  
Endoscopy 
Abnormal upper GI endoscopic lesions were significantly more common in TB as 
compared to CD (p value – 0.014). 
In our study, abnormal endoscopic esophageal findings were detected in 35% TB 
cases but, were not present in any of the 20 CD cases (p value - 0.003). The low 
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frequency of esophageal endoscopic involvement in Crohn’s disease was in 
concordance with other studies by Wagtman et al (0.7%) and Schmitz Moorman et al 
(15%).  
Among the cases with esophageal involvement, the middle third of the esophagus was 
the site most frequently involved (5 of 7 cases) and the most common endoscopic 
finding in TB was ulcerations (30%). The ulcerations were generally single in number, 
with a median size of 0.87cm, with the largest measuring 2.5cm.  Nagi et al, Jain et al 
and Abid et al had also reported similar findings in their studies (5,24,33). In our 
study, one case also showed ulcero-proliferative tumour like growth as described by 
Nagi et al and Li Q et al (33,79). 
The frequency of gastric endoscopic abnormalities was almost the same in both TB 
(50%) and CD (40%).  The abnormal endoscopic gastric findings included erosions 
edema, erythema, thickening, deformity and submucosal nodules. One case with TB 
shows an ulcero-proliferative tumour like growth. However, there were no significant 
difference between TB and CD. 
Abnormal duodenal endoscopic findings were significantly more common in TB as 
compared to CD (p value=0.05). Erosions, ulcerations, nodular mucosa, thickening, 
erythema and edema were the common findings reported in both TB and CD cases 
with no significant statistical difference in their prevalence. 
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It must also be mentioned that in our study, among the CD cases, the stomach was the 
most common site to show endoscopic abnormalities and this finding was similar to 
that demonstrated in other studies (4,7,47). 
Histology 
Granulomatous inflammation –  
In the upper gastrointestinal tract, granulomatous inflammation due to TB and CD in 
all the sites showed features similar to those in the lower gastrointestinal tract as 
described in previous published studies from our institute(71,75). 
 In our study, in the upper GIT, higher numbers of granulomas were observed in TB as 
compared to CD. More than or equal to 4 granulomas per biopsy was significantly 
more common in TB than CD. 
The presence of large granulomas was another differentiating feature between TB and 
CD. Biopsies with at least one large granuloma were significantly more common in 
TB as compared to CD. Also, all the granulomas were either small or medium sized. 
In our study, disorganised granulomas were significantly more common in CD than in 
TB, although it must be noted that disorganised granulomas were also present in TB. 
Confluence of granulomas was a significant finding in TB.  All the granulomas in CD 
were discrete. Furthermore, the presence of lymphoid cuff was also more common in 
TB than CD; however this difference was not statistically significant. 
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Another distinguishing feature between TB and CD was the differential localisation of 
granulomas. TB granulomas were more commonly located within ulcerations, deep 
mucosa and submucosa.  
Also, in gastric mucosal biopsies, perifoveolar granulomas were more common in CD 
than TB, however, this difference was not statistically significant. 
Schmitz – Moorman et al and van Hogezand et al reported that granulomatous 
inflammation was more frequent in stomach as compared to other sites in upper 
gastrointestinal TB (4,17). A similar finding was demonstrated in our study too. 
Other mucosal changes 
Esophagus – Ulcerations were a common histological finding in esophageal TB. 
Increase in intraepithelial lymphocytes was present in all the TB esophageal biopsies. 
The intraepithelial lymphocytes were predominantly located in both the peripapillary 
and interpapillary region (83.33%). In four of the cases, there was only a mild increase 
in IELs and only one case each had moderate and marked increase in IELs 
respectively. 
Moderate to marked lamina propria chronic inflammation as well as moderate lamina 
propria activity were also common histological findings in esophageal. 
Stomach - Moderate chronic lamina propria inflammation was more common in TB 
(47%) than CD (29%), however this difference was not statistically significant. 
Features like fibrosis, lymphoid aggregates and moderate glandular atrophy were 
significantly more common in TB than CD.  
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Focally enhanced gastritis was a statistically significant finding in CD (62%) in 
contrast to TB (p value – 0.39). This finding was in concordance with studies by 
Oberhueber et al (76%) and Sharif et al (65%) (26,80).  
However, it must be also be emphasized that the entity of focally enhanced gastritis 
was also noted in 5% of TB biopsies, thereby highlighting that this finding is not 
exclusive to CD.  
Moderate foveolitis and moderate lamina activity were more common in TB as 
compared to CD. 
Duodenum – Crypt villous alteration with villous atrophy was significantly more 
common in TB (50% mild, 16% moderate) than CD (p value – 0.036). 
Moderate chronic lamina propria inflammation was more common in TB (42%) than 
CD (6.25%), however this difference was not statistically significant (p value – 
0.072). Lymphoid aggregates were also significantly more common in TB than CD. 
Other mucosal changes such as cryptitis, crypt hyperplasia, pyloric metaplasia and 
fibrosis were more frequent in TB than CD, but none of these differences were 
statistically significant. 
 
 
 
 
  
 
 
 
 
 
 
 
 
CONCLUSIONS 
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CONCLUSIONS 
 
We studied 40 cases with granulomatous inflammation in mucosal biopsies from the 
upper gastrointestinal tract that included 20 cases with a final diagnosis of 
Tuberculosis and 20 cases with a final diagnosis of Crohn’s disease. We found the 
following- 
1. A younger age at presentation and longer duration of symptoms were more 
commonly associated with CD. 
2. Necrotic lymphadenopathy on CT imaging was significantly more common in 
TB. The mesenteric lymph nodes were more commonly involved in TB than 
CD. In our study, the lesser omental, greater omental and para-aortic lymph 
node groups were involved only in TB. 
3. Abnormal endoscopic findings in the upper gastrointestinal tract were more 
frequent in TB than CD. In Crohn’s disease, a few of the cases had small and 
linear erosions. Tumour like lesions were present in  two cases of Tuberculosis. 
4. The salient distinguishing features of TB at any site were the presence of ≥4 
granulomas, large granulomas, confluent granulomas and the location of 
granulomas within ulcer bases and in the submucosa. Disorganised granulomas 
were more common in Crohn’s disease. 
5. Focally enhanced gastritis was more common in Crohn’s disease than in 
Tuberculosis. However, glandular atrophy, activity, fibrosis and lymphoid 
aggregates were more common in the gastric mucosa affected by  Tuberculosis 
than Crohn’s disease. 
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6. Involvement of the esophagus and duodenum by granulomatous inflammation 
was more common in TB than CD. 
7. Esophageal involvement by Tuberculosis was associated with ulceration, 
moderate to marked chronic inflammation, activity and increase in 
intraepithelial lymphocytes. 
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LIMITATIONS 
 
 The sample size was limited as a large number of patients with an initial 
diagnosis of Crohn’s disease or Tuberculosis were lost to follow up. 
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 ANNEXURES 
 
 
  
PROFORMA 
CLINICAL DETAILS 
1) Serial Number: 
2) Biopsy Number: 
3) Age:    
4) Gender: 
5) Treatment history: 
6) Duration of symptoms 
7) Presence or absence of symptoms – Dyspepsia/Vomiting/Hematemesis/Altered bowel 
habits/Diarrhoea/Melena/Haematochezia/Loss of weight/Loss of appetite/Abdominal 
pain/Dysphagia/Fever 
8) ESR: 
9) CRP: 
10) AFB smear: 
11) Xpert TB PCR: 
12) QuantiFERON GOLD: 
13) Blood borne viruses 
14) Endoscopy: Normal/Abnormal. If abnormal,  
a. Esophagus: 
Erosions/Ulcerations/Edema/Erythema/Nodularity/Thickening/Varices/Deformity/Ul
cero-proliferative growth. 
b. Stomach: Erosions/Ulcerations/Edema/Erythema/Nodularity/Thickening/Ulcero-
proliferative growth/Submucosal nodules/Deformity. 
c. Duodenum: 
Erosions/Ulcerations/Edema/Erythema/Nodularity/Thickening/Deformity/Lymphang
ectasia/Granular mucosa 
15) Radiology 
a. Esophagus –Mass/Thickening 
b. Gastric – Mass/Thickening 
c. Duodenum – Mass/Thickening 
d. Lung lesions 
e. Ileocaecal involvement 
f. Liver/Spleen lesions 
g. Lymphadenopathy –  
i. Presence of necrosis 
ii. Involvement of periesophageal, Perigastric, periduodenal, lesser omental, 
greater omental or para-aortic lymph nodes 
 
 
  
GASTRIC MUCOSAL BIOPSIES 
1. Biopsy Number 
2. Location – Body/Fundus/Antrum/Incisura 
3. Number of fragments –  
4. Number of low power fields –  
5. Presence of erosions/ulcerations –  
6. Foveolar architecture alteration – Preserved/Mild/Moderate/Marked 
7. Glandular atrophy – Absent/Mild/Moderate/Marked 
8. Intestinal metaplasia -  Absent/Mild/Moderate/Marked 
9. Foveolitis - Absent/Mild/Moderate/Marked 
10. Foveolar abscess – Absent/Present 
11. Focally enhanced inflammation  
a. Absent/Present 
b. Number of foci 
c. Perifoveolar/Periglandular 
12. Severity of lamina propria inflammation –Mild/Moderate/Marked 
13. Distribution of lamina propria chronic inflammation – Patchy/Diffuse 
14. Lamina propria neutrophils - Absent/Mild/Moderate/Marked 
15. Fibrosis-Present/Absent 
16. Lymphoid aggregates – Present/Absent 
17. Helicobacter pylori – Present/Absent 
18. Histiocytic aggregates – Present/Absent 
19. Granulomatous inflammation – Present/Absent 
a. Number of granulomas 
b. Discrete/Confluent 
c. Size 
d. Disorganised/Compact 
e. Location 
f. Lymphoid cuff 
g. Giant cells -  Foreign body/Langhan’s 
h. Necrosis 
i. Caseation 
j. Acid fast bacilli 
k. Perifoveolar 
l. Periglandular 
 
 
 DUODENAL MUCOSAL BIOPSIES 
1. Biopsy Number 
2. Location – D1/D2/D1 & D2 
3. Number of fragments –  
4. Number of low power fields –  
5. Presence of erosions/ulcerations –  
6. Crypt villous architecture alteration – Preserved/Mild/Moderate/Marked 
7. Villous atrophy – Absent/Mild/Moderate/Marked 
8. Crypt hyperplasia – Present/Absent 
9. Brunner’s gland hyperplasia – Absent/Mild/Moderate/Marked 
10. Neutrophils in villous epithelium – Present/Absent 
11. Increase in intraepithelial lymphocytes – Present/Absent 
12. Number of IELs. 
13. Cryptitis – Present/Absent 
14. Crypt abscess – Present/Absent 
15. Severity of lamina propria chronic inflammation – Mild/Moderate/Marked 
16. Distribution of lamina propria chronic inflammation – Patchy/Diffuse 
17. Lamina propria neutrophils - Absent/Mild/Moderate/Marked 
18. Metaplasia-Present/Absent 
19. Fibrosis – Present/Absent 
20. Lymphoid aggregates – Present/Absent 
21. Histiocytic aggregates – Present/Absent 
22. Granulomatous inflammation – Present/Absent 
a. Number of granulomas 
b. Discrete/Confluent 
c. Size 
d. Disorganised/Compact 
e. Location 
f. Lymphoid cuff 
g. Giant cells -  Foreign body/Langhan’s 
h. Necrosis 
i. Caseation 
j. Acid fast bacilli 
 
 
 
 
 
 
 
 
 
 
 
 ESOPHAGEAL MUCOSAL BIOPSIES 
1. Biopsy Number 
2. Location – D1/D2/D1 & D2 
3. Number of fragments –  
4. Number of low power fields –  
5. Presence of erosions/ulcerations –  
6. Acanthosis –  Absent/Mild/Moderate/Marked 
7. Parakeratosis – Absent/Mild/Moderate/Marked 
8. Basal cell hyperplasia – Present/Absent 
9. Papillary elongation – Present/Absent 
10. Increase in intraepithelial lymphocytes – Absent/Mild/Moderate/Marked 
11. Intraepithelial eosinophils - Absent/Mild/Moderate/Marked 
12. Severity of lamina propria chronic inflammation – Mild/Moderate/Marked 
13. Distribution of lamina propria chronic inflammation – Patchy/Diffuse 
14. Lamina propria neutrophils - Absent/Mild/Moderate/Marked 
15. Fibrosis – Present/Absent 
16. Lymphoid aggregates – Present/Absent 
17. Histiocytic aggregates – Present/Absent 
18. Granulomatous inflammation – Present/Absent 
a. Number of granulomas 
b. Discrete/Confluent 
c. Size 
d. Disorganised/Compact 
e. Location 
f. Lymphoid cuff 
g. Giant cells -  Foreign body/Langhan’s 
h. Necrosis 
i. Caseation 
j. Acid fast bacilli 
 
 
 
